DNMT3A mutations are rare in childhood acute myeloid leukemia

Childhood acute myeloid leukemia (AML) is a complex disease of the hematopoietic stem cell. Overall survival is relatively low with an overall survival rate of 50–70%. Besides cytogenetic changes and response to induction therapy, molecular aberrations are important prognostic markers that can

• Publication year

  2011

• Venue

  Haematologica

• Publication date

  2011-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3324/haematol.2011.046839PMID 21685466PMCID PMC3148921
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNMT3A mutations in acute myeloid leukemia

  2011influential reference
• Leukemic mutations in the methylation‐associated genes DNMT3A and IDH2 are rare events in pediatric AML: A report from the Children's Oncology Group

  2011cited by this paper
• Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia

  2011cited by this paper
• Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML–BFM and DCOG study groups

  2011cited by this paper
• Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.

  2011cited by this paper
• CNS irradiation in pediatric acute myleoid leukemia: Equal results by 12 or 18 Gy in studies AML‐BFM98 and 2004

  2011cited by this paper
• DNMT3A mutations in acute myeloid leukemia.

  2010cited by this paper
• Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia.

  2009cited by this paper
• Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML

  2009cited by this paper
• Less toxicity by optimizing chemotherapy, but not by addition of granulocyte colony-stimulating factor in children and adolescents with acute myeloid leukemia: results of AML-BFM 98.

  2006cited by this paper
• CEBPa mutations in childhood acute myeloid leukemia

  2005cited by this paper
• Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials

  2005cited by this paper
• CEBPalpha mutations in childhood acute myeloid leukemia.

  2005cited by this paper
• FLT3 mutations in childhood acute lymphoblastic leukemia.

  2004cited by this paper
• CEBPα mutations in childhood acute myeloid leukemia

  2004cited by this paper

• Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies

  2023cites this paper
• The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia

  2023cites this paper
• Vitamin D-Binding Protein and Acute Myeloid Leukemia: A Genetic Association Analysis in Combination with Vitamin D Levels

  2022cites this paper
• Proviral Integration of Moloney Virus-2 (PIM-2) Expression Level as a Prognostic Marker in Patients with Acute Myeloid Leukemia

  2022cites this paper
• Prognostic Value of Interleukin-17 A Gene Polymorphism and Serum IL-17 Levels in Adult Acute Myeloid Leukaemia Patients

  2020cites this paper
• Epigenetic Dysregulation in Pediatric Leukemia

  2018cites this paper
• Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemia.

  2018cites this paper
• DNMT3A in Leukemia.

  2017influential citation
• Exploring Mechanisms Linking Signal Transduction and Cancer Stem Cell Expansion

  2017influential citation
• Molecular characteristic of acute leukemias with t(16;21)/FUS-ERG

  2017cites this paper
• DNMT3A mutations in Chinese childhood acute myeloid leukemia

  2017cites this paper
• MGMT promoter methylation as a potential prognostic marker for acute leukemia

  2017cites this paper
• Gene Mutations as Emerging Biomarkers and Therapeutic Targets for Relapsed Acute Myeloid Leukemia

  2017influential citation
• Insights into cell ontogeny, age, and acute myeloid leukemia.

  2015cites this paper
• DNMT3A in haematological malignancies

  2015cites this paper
• Insights into Cell Ontogeny, Age and Acute Myeloid Leukaemia Normal Biology of Haematopoietic Cell Ageing

  2015cites this paper
• DNMT3A mutations and prognostic significance in childhood acute lymphoblastic leukemia

  2015cites this paper
• SWI/SNF Subunits SMARCA4, SMARCD2 and DPF2 Collaborate in MLL-Rearranged Leukaemia Maintenance

  2015cites this paper
• Acute myeloid leukemia with DNMT3A mutations

  2014cites this paper
• Atlas of Genetics and Cytogenetics in Oncology and Haematology

  2014cites this paper
• Genomic Characterization of Acute Leukemias

  2014cites this paper
• Characterization of relapsed Acute Myeloid Leukemia

  2014cites this paper
• Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia

  2014cites this paper
• Role of DNA Methyltransferases and DNA Methylation in Cell Fate Decisions During Blood Cell Development and Leukemia

  2014cites this paper
• Feature-Based Classification of Amino Acid Substitutions outside Conserved Functional Protein Domains

  2013cites this paper
• Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT 3 A mutations

  2013cites this paper
• Cooperating gene mutations in childhood acute myeloid leukemia with special reference on mutations of ASXL1, TET2, IDH1, IDH2, and DNMT3A.

  2013influential citation
• DNMT 3 A special reference on mutations of ASXL 1 , TET 2 , IDH 1 , IDH 2 , and Cooperating gene mutations in childhood acute myeloid leukemia with

  2013influential citation
• Whole-exome sequencing in adult ETP-ALL reveals a high rate of DNMT3A mutations.

  2013cites this paper
• DNMT3A special reference on mutations of ASXL1, TET2, IDH1, IDH2, and Cooperating gene mutations in childhood acute myeloid leukemia with

  2013cites this paper
• Novel Molecular Acquisitions in Leukemias

  2013cites this paper
• DNMT3A (DNA (cytosine-5-)-methyltransferase 3 alpha)

  2013cites this paper
• Cancer Genomics

  2013cites this paper
• A somatic EZH2 mutation in childhood acute myeloid leukemia

  2012cites this paper
• Mutations in DNA Methyltransferase (DNMT3A) Observed in Acute Myeloid Leukemia Patients Disrupt Processive Methylation

  2012cites this paper
• Mutant DNMT3A: teaming up to transform.

  2012cites this paper
• Update on cytogenetic and molecular changes in myelodysplastic syndromes

  2012cites this paper
• Phase I and pharmacokinetic study of elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, in adults with refractory hematological malignancies

  2012cites this paper
• DNMT3A mutations are rare in childhood acute myeloid leukaemia, myelodysplastic syndromes and juvenile myelomonocytic leukaemia

  2012cites this paper
• Abnormal promoter DNA methylation in juvenile myelomonocytic leukemia is not caused by mutation in DNMT3A.

  2011cites this paper
• Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association

  2011cites this paper
• DNA methyltransferase 3a hot-spot locus is not mutated in pediatric patients affected by acute myeloid or T-cell acute lymphoblastic leukemia: an Italian study

  2011cites this paper
• Is there still a place for myeloablative regimen to transplant young adults with sickle cell disease?

  2011cites this paper
• Patient DNMT3A Protein Age Sex FAB WBC Platelets Karyotype Other CR Relapse Transplantion Survival status/ mutation change (years)

  2011cites this paper